Search Results - Sara Varea
- Showing 1 - 5 results of 5
-
1
-
2
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia. by Cristina Pérez, Nicolas Martínez-Calle, José Ignacio Martín-Subero, Victor Segura, Eric Delabesse, Marta Fernandez-Mercado, Leire Garate, Sara Alvarez, José Rifon, Sara Varea, Jacqueline Boultwood, James S Wainscoat, Juan Cruz Cigudosa, María José Calasanz, Nicholas C P Cross, Felipe Prósper, Xabier Agirre
Published in PLoS ONE (2012-01-01)Get full text
Article -
3
Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h by Daniel Munárriz, Luis Gerardo Rodríguez-Lobato, Lucía López-Corral, Cristina Arnaldos-Pérez, Valentín Cabañas, Nieves López-Muñoz, Aina Oliver-Caldés, Juan Carlos Ponce, Juan Luis Reguera, Ana África Martín, Núria Martínez-Cibrián, Natalia Tovar, Julio Delgado, Elena Guillen, Sara Varea, Paula Rodríguez-Otero, Álvaro Urbano-Ispizua, José María Moraleda, Joaquín Martínez-López, María-Victoria Mateos, Verónica González De la Calle, Europa Azucena González-Navarro, Carlos Fernández de Larrea
Published in Frontiers in Immunology (2025-10-01)Get full text
Article -
4
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma by Inés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés, Juan Carlos Soler-Perromat, Verónica González-Calle, David F. Moreno, Valentín Cabañas, Nieves López-Muñoz, Álvaro Bartolomé-Solanas, Marta Español-Rego, Juan Luis Reguera-Ortega, Laura Rosiñol, Lucía López-Corral, Natalia Tovar, Luis Gerardo Rodríguez-Lobato, Rosa Maria Alvarez Perez, Sara Varea, Eulàlia Olesti, Adolfo Gomez-Grande, Laura Frutos, Pilar Tamayo, Manel Juan, José M. Moraleda, Álvaro Urbano-Ispizua, E. Azucena González-Navarro, Joaquín Martínez-López, Maria-Victoria Mateos, Xavier Tomás, Xavier Setoain, Carlos Fernández de Larrea
Published in Blood Advances (2025-02-01)Get full text
Article -
5
Efficacy and safety of the academic anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma by Núria Martínez‐Cibrián, Valentín Ortiz‐Maldonado, Marta Español‐Rego, Leticia Alserawan, Sergio Navarro, Nil Albiol, Miquel Lozano, Paola Charry, Laura Magnano, Andrea Rivero, Juan G. Correa, Pablo Mozas, Albert Cortés‐Bullich, Carlos Jiménez‐Vicente, Eva Giné, Mercedes Montoro‐Lorite, Carla Ramos, Pilar Ayora, Hugo Calderón, María Sánchez‐Castañón, Daniel Benítez‐Ribas, Juan J. Mata‐Molanes, Kelly Rojas, Xavier Setoaín, Sonia Rodríguez, Adrià Murias, Pau Alcubilla, Sara Varea, Eulalia Olesti, Mireia Bachiller, María Calvo‐Orteu, Carla Sans‐Pola, Joaquín Sáez‐Peñataro, Carlos Fernández deLarrea, Armando López‐Guillermo, E. Azucena González‐Navarro, Manel Juan, Julio Delgado
Published in HemaSphere (2025-09-01)Get full text
Article
